Literature DB >> 26446297

Considerations for clinically-relevant nanomedicine therapies for chronic diseases.

Andrew Owen1, Steve Rannard2.   

Abstract

Entities:  

Keywords:  chronic disease; nanocarriers; patient adherence; solid drug nanoparticles

Mesh：

Substances：

Year:  2015        PMID： 26446297     DOI： 10.2217/nnm.15.135

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  2 in total

1.  Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies.

Authors:  Marco Giardiello; Neill J Liptrott; Tom O McDonald; Darren Moss; Marco Siccardi; Phil Martin; Darren Smith; Rohan Gurjar; Steve P Rannard; Andrew Owen
Journal:  Nat Commun       Date:  2016-10-21       Impact factor: 14.919

Review 2.  Recent advances in "smart" delivery systems for extended drug release in cancer therapy.

Authors:  Regina-Veronicka Kalaydina; Komal Bajwa; Bessi Qorri; Alexandria Decarlo; Myron R Szewczuk
Journal:  Int J Nanomedicine       Date:  2018-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.